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ABSTRACT 
Objective: This study was designed to identify quantifiable parameters to track 
performance improvements brought about by the implementation of a critical pathway for 
complex alimentary tract surgery. 
 
Background: Pancreaticoduodenectomy (PD) is a complex general surgical procedure 
performed in varying numbers at many academic institutions. Originally associated with 
significant perioperative morbidity and mortality, multiple studies have now shown that 
this operation can be performed quite safely at high volume institutions that develop a 
particular expertise. Critical pathways are one of the key tools used to achieve 
consistently excellent outcomes as these institutions.  It remains to be determined if 
implementation of a critical pathway at an academic institution with prior moderate 
experience with PD will result in performance gains and improved outcomes. 
 
Methods: Between January 1, 2004 and October 15, 2006 135 patients underwent PD, 44 
before the implementation of a critical pathway on October 15, 2005, and 91 after. 
Perioperative and postoperative parameters were analyzed retrospectively to identify 
those that could be used to track performance improvement and outcomes. Key aspects of 
the pathway include spending the night of surgery in the intensive care unit with careful 
attention to fluid balance, early mobilization on post-operative day one, aggressive early 
removal of encumbrances such as nasogastric tubes and urinary catheters, early post-
operative feeding, and targeting discharge for postoperative day 6 or 7. 
 
Results: The pre- and post-pathway implementation groups were not statistically 
different with regards to age, sex, race, or pathology (malignant versus benign). 
Perioperative mortality, operative blood loss, and number of transfused units of packed 
red blood cells were also similar. As compared to the pre-pathway group, the post-
pathway group had a significantly shorter postoperative length of stay (13 versus 7 days, 
P C 0.0001), operative time (435 ± 14 minutes versus 379 ± 12 minutes, P C 0.0001), and 
in room non-operative time (95 ± 4 minutes versus 76 ± 2 minutes, P C 0.0001). Total 
hospital charges were significantly reduced from $240,242 ± $32,490 versus $126,566 ± 
$4883 (P C 0.0001) after pathway implementation. Postoperative complication rates 
remained constant (44% pre-pathway versus 37% after, P = NS). Readmission rates were 
not negatively affected by the reduction in length of stay, with a 7% readmission rate 
prior to implementation and a 7.7% rate after implementation. 
 
Conclusion: Implementation of a critical pathway for a complex procedure can be 
demonstrated to improve short-term outcomes at an academic institution. This 
improvement can be quantified and tracked and has implications for better utilization of 
resources (greater OR and hospital bed availability) and overall cost containment. With a 
very conservative estimate of 75 pancreaticoduodenectomies per year by this group, this 
translates to a savings of 450 hospital days and over $8,550,000 in hospital charges on an 
annual basis. As we enter the “pay for performance” era, institutions will be required to 
generate such data in order to retain patient volumes, attract new patients, and receive 
“incentive payments” for high quality services rendered.  
INTRODUCTION 
 Healthcare providers are under increasing pressure to control costs while 
maintaining or improving outcomes.  The implementation of critical pathways (or fast-
tracking protocols) is one approach to this challenge that has been applied to many 
different surgical procedures (1-10). Critical pathways are best described as structured 
multidisciplinary care plans that detail the essential steps in the care of patients with a 
specific clinical problem (11). They provide a timeline of the ideal sequence of treatment 
related events with daily goals, to assist care providers in administering care with optimal 
efficiency. Multiple reports have credited these pathways with improving efficiency, 
reducing length of hospital stay, and helping to control costs (1, 4, 5, 9).  
Recently, several reviews have been published that question the true value of 
critical pathways (11-15). The criticisms contained in these articles include (1) the 
possibility that performance improvements are the result of patient selection bias, with 
only healthy patients “cherry picked” for inclusion in pathway treatment giving unfair 
advantage over unfiltered pre-pathway controls or, (2) that only pathway implementation 
with substantial improvements get reported (12). Additionally, the articles collectively 
cite a universal decrease in length of hospital stay as a secular trend across all of 
medicine, for which pathways are being given unfair credit (14). 
Recognizing these issues, we evaluated the impact of introducing a critical 
pathway for a complex general surgical procedure (pancreaticoduodenectomy) at a major 
academic institution. Pancreaticoduodenectomy is a procedure performed in varying 
numbers at many academic institutions. Originally associated with significant 
perioperative morbidity and mortality, multiple studies have now shown that this 
operation can be performed quite safely at high volume institutions that develop a 
particular expertise (16). Critical pathways have been cited as one of the key tools used to 
achieve consistently excellent outcomes as these institutions. The implementation of the 
pathway for pancreaticoduodenectomy was timed to coincide with an expected rise in 
case volume. The aim of this study was to determine if implementation of a critical 
pathway at an academic institution with prior moderate experience with PD would result 




The records of 135 consecutive patients undergoing pancreaticoduodenectomy at Thomas 
Jefferson University Hospital from January 1, 2004 through October 15, 2006 were 
reviewed. A critical pathway for pancreaticoduodenectomy was implemented on October 
15, 2005 at the time of the arrival of a new Chair of Surgery (C.J.Y.) and after the 
recruitment of a team focused on pancreatic surgery (E.P.K. and P.K.S.). Additional 
critical pathways for distal pancreatectomy and palliative double bypass 
(gastrojejunostomy and hepaticojejunostomy) were similarly implemented, but are not 
part of this report. Fourty-four patients treated prior to the implementation of the pathway 
were compared to 91 patients treated after pathway implementation. Patients undergoing 
total pancreatectomy and right-sided completion pancreatectomy were also included, as 
they were treated according to pathway standards. Patients with both malignant and 
benign disease were included in this analysis. All patients undergoing 
pancreaticoduodenectomy after pathway implementation were treated according to 
pathway standards and are included in this analysis. Pathway implementation included 
numerous formal educational sessions with anesthesia, nursing, nutrition, and surgical 
house staff. Furthermore, pathway implementation included formal initiation of 
computerized standard order sets as part of the Thomas Jefferson University Hospital 
computerized order entry system. 
 
Components of the critical pathway  
The pathway utilized was previously developed and utilized at a high volume 
institution (Johns Hopkins Medical Institution) by two of the participating surgeons 
(C.J.Y. and E.P.K.) and by an experienced clinical nurse practitioner (P.K.S.). The 
pathway outlines the daily progress made by a patient without postoperative 
complications after surgery. (Table 1) Expectations with respect to all aspects of care are 
outlined for each postoperative day. Templates were generated for standardized order sets 
in the hospital computerized order entry system.  
Pathway execution begins at the pre-operative office visit, with education of 
patients and families about general pathway goals and expectations, including the 
targeting of discharge for postoperative day 6 or 7. All patients are instructed to ingest a 
mild mechanical bowel prep at home the night before surgery and patients are admitted as 
same day surgery patients. Consents for operation and research studies are obtained in 
advance of the day of surgery. Standardized orders for perioperative antibiotics and deep 
venous thrombosis (DVT) prophylaxis (subcutaneous heparin and thromboembolic 
deterrent (TED) stockings) are utilized in the preoperative holding area. In the operating 
room, patients are routinely monitored, usually with a radial arterial catheter. Sequential 
compression devices (SCDs) are utilized. Central venous access is obtained only when 
deemed necessary by the attending anesthesiologist. Epidural analgesia is not utilized. A 
nasogastric tube is placed after induction of anesthesia and two closed suction drains are 
placed during surgery. 
Patients are extubated in the operating room when no contraindication exists and 
spend the night of surgery in an intensive care setting. Electrolyte abnormalities and fluid 
status are aggressively monitored and corrected. Postoperative analgesia is provided with 
intravenous narcotics via a patient controlled anesthesia (PCA) device. All patients also 
receive an intravenous proton pump inhibitor (PPI) and a beta-blocker, in addition to 
subcutaneous heparin and 24 hours of prophylactic antibiotic coverage.  
Patients are mobilized in the early morning of the first postoperative day. The 
nasogastric tube is removed that morning and patients are started on sips of water and ice 
chips (C 30cc per hour). SCDs are discontinued, while TED stockings, subcutaneous 
heparin, intravenous beta-blockade, and PPI are continued until hospital discharge. 
Patients are transferred to the floor and ambulated with the assistance of staff. 
On postoperative day two, patients are advanced to an unlimited clear liquid diet. 
The urinary catheter is removed and patients are assisted in increasing their frequency 
and duration of ambulation. Fluids are minimized and most patients receive low dose 
diuretics to aid in the mobilization of the perioperative fluid which was administered 
intraoperatively and immediately postoperatively.  
In most patients the initiation of a regular diet begins on postoperative day three, 
with oral pancreatic enzyme supplementation. Medications, including beta-blockade and 
PPI, are continued as intravenous formulations until postoperative day four to assure that 
a diet is tolerated. Intravenous fluids are discontinued on postoperative day four. The 
surgical drains (typically two) are removed sequentially on postoperative days four and 
five, if appropriate. Medical oncology and radiation oncology are consulted when 
appropriate on postoperative day five. Pre-printed discharge instructions are distributed to 
allow time for patients and their families to review and formulate questions prior to 
discharge. 
On postoperative days six and seven, patients continue to increase activity levels 
and arrangements for discharge are made. Discharge is targeted for postoperative day six 
or seven. A follow-up appointment is scheduled for four weeks after discharge. Typical 
discharge medications include necessary preoperative medications plus a PPI, pancreatic 
enzymes, and analgesics (typically an oxycodone containing oral preparation). 
 
Patient outcomes 
Data collected for analysis included demographics, diagnosis, operative blood 
loss and blood transfusions, length of operation, length of non-operative time in operating 
room, perioperative complication rates, perioperative mortality, length of postoperative 
hospital stay, total hospital charges, and readmission rate. Data were obtained from 
retrospective chart review for patients treated prior to implementation of the critical 
pathway and from a prospective clinical data base for patients treated after 
implementation. Common postoperative complications analyzed included pancreatic 
fistula (defined as output of more than 30 ml per day of amylase rich fluid (more than 3 
times serum value) for greater than 10 days postoperatively), delayed gastric emptying 
(DGE) (defined as persistent vomiting or inability to tolerate diet requiring replacement 
of nasogastric tube), and wound infection (defined by standard clinical criteria and 
requiring intervention). Perioperative mortality was defined as death within 30 days of 
surgery. Readmission rate was calculated based upon readmission to Thomas Jefferson 
University Hospital within 30 days of discharge. Length of operation was obtained from a 
query of the Thomas Jefferson University Hospital operating room information 
management system.  Financial data were provided by JeffCare, Inc., the Jefferson Health 
System’s Physician Hospital Organization.  
 
Statistical analyses 
Data analyses to determine level of significance of differences in characteristics 
and outcomes between the two groups of patients were performed using a 2-sample t test 
or Fisher’s exact test, where appropriate. Data are expressed as mean ± standard error 
where applicable or as a percentage where noted. Data on length of stay are presented as 




Demographics (Table 2) 
 The pre-pathway and post-pathway groups were similar with respect to the 
analyzed demographic data. Median age (60 years pre-pathway versus 66 years post-
pathway) was not significantly different between the groups. Similarly, distribution by 
sex (47% female pre-pathway versus 55% female post-pathway) and race (79% white, 
12% African American, 9% other pre-pathway versus 87% white, 5% African American, 
8% other post-pathway) was also comparable between the groups. The pathology in the 
resection specimen was also similar with 74% of the pre-pathway patients undergoing 
resection for malignant disease, compared to 70% of the post-pathway patients. 
 
Intraoperative Parameters (Table 2) 
 Several intraoperative parameters were assessed. Operative blood loss (549 ± 48 
ml pre-pathway versus 646 ± 29 ml post-pathway) and units of packed red blood cells 
transfused during surgery (0.72 ± 0.16 units pre-pathway versus 0.64 ± 0.13 units post-
pathway) did not significantly change with the implementation of the critical pathway. 
The length of operation as well as the length of time patients spend in the operating room 
did change significantly, however. Operative length (from incision to closure) decreased 
from 435 ± 14 minutes pre-pathway to 379 ± 12 minutes post-pathway (P C 0.0001). 
Non-operative time spent in the operating room (defined as the time from entry into room 
until incision plus the time from closure until room departure) fell from 95 ± 4 minutes 
pre-pathway to 76 ± 2 minutes post-pathway (P C 0.0001). 
 
Post-operative parameters (Table 3) 
 The perioperative complication rate for pancreaticoduodenectomy did not change 
significantly with the implementation of the critical pathway. The overall perioperative 
complication rate was 44% prior to the implementation of the critical pathway and 37% 
afterwards. Rates for specific complications including pancreatic fistula (9% pre-pathway 
versus 2% post-pathway), DGE (7% pre-pathway versus 8% post-pathway), and wound 
infection (9% pre-pathway versus 13% post-pathway) were similar as well. Other less 
common complications including atrial fibrillation and other cardiovascular events, 
pneumonia, intra-abdominal abscess (not containing amylase rich fluid) requiring 
interventional radiology drainage, small bowel obstruction, and deep venous thrombosis 
were also equally distributed between the groups (25% versus 20%). The 30 day 
mortality rate before and after pathway implementation was unchanged, at 2.3% pre-
pathway compared to 1.1% post-pathway. Of note, postoperative length of hospital stay 
was significantly shortened by utilization of the critical pathway. Prior to pathway 
implementation the median length of hospital stay was 13 days. Implementation of the 
pathway resulted in a reduction of length of stay to 7 days (P C 0.0001). This paralleled a 
reduction in total hospital charges from $240,242 ± $32,490 pre-pathway to $126,566 ± 
$4883 post-pathway (P C 0.0001). The reduction in length of hospital stay did not result 
in an increase in hospital readmissions, with 30 day readmission rates being 7% for pre-
pathway patients and 7.7% for post-pathway patients.  
 
DISCUSSION 
The provision of high quality, cost-effective health care is a goal shared by all 
health care providers. As we approach the “pay-for-performance” era, strategies that 
maintain or improve quality outcomes while increasing the efficient use of limited 
resources gain increasing value. Critical pathways have been adopted at many institutions 
as a means to promote quality and efficient care. However, there are detractors who 
question the value of critical pathways.  
A number of studies have been published that question the value of critical 
pathways (11-14). These critiques revolve around three main points. First, critics claim 
that pathways are simply superimposed upon underlying, pre-existing trends. The 
reductions in length of stay cited by critical pathway authors as proof of efficacy are 
attributed, by critics, to overall trends in healthcare and outside economic pressures 
targeting shorter lengths of stay. Critics note that lengths of stay were declining prior to 
pathway implementation and that rates of decline were not increased by most pathways 
(13). Secondly, the selective application of pathways in some reports (4) is used by critics 
as evidence that the performance improvements attributed to critical pathways are simply 
the result of patient selection bias (12). Critics claim, accurately, that if healthier patients 
are placed on critical pathways, while patients with greater co-morbidities are placed in 
non-pathway control groups, then outcomes will invariably improve, independent of the 
efficacy of the pathway itself. Thirdly, critics claim that pathways require substantial 
resources to develop, implement and maintain (14). They claim that critical pathways 
depend on local processes and organizational structure requiring the development of 
unique pathways for each institution (13). The costs associated with this development 
have been alleged to offset the economic benefits of pathway implementation. 
This study was designed to assess the impact of implementing a critical pathway 
at a major academic institution. The pathway was implemented fully formed, timed to 
coincide with a planned significant increase in operative volume and was introduced to 
all health care professionals at Thomas Jefferson University Hospital to allow comment 
and “buy-in.” Its implementation was acute, as opposed to a gradual phase in over weeks 
or months. The hypothesis was that by using a critical pathway, a large institution with 
moderate experience with a particular complex procedure could significantly increase 
operative volume, while maintaining or improving measurable quality associated 
outcomes. 
Several observations can be drawn from our results. The similarity in 
demographics argues against selection bias being the basis for the performance 
improvements described. Concerning measured intraoperative parameters, pathway 
implementation did not impact factors that can be considered surgeon dependant, such as 
blood loss or total units of packed red cells transfused. It did improve parameters that can 
be classified as system or multi-disciplinary team based, such as non-operative time in 
the room. This can be explained by such pathway elements as standardized central 
venous access and preoperative management and standardization of postoperative patient 
destination, eliminating delays associated with queries about the need for a monitored or 
ICU bed. 
Postoperative parameter improvements that can be linked to pathway 
implementation start with postoperative length of hospital stay. Multiple factors 
contributed to the reduction in length, from altering patient expectations to education of 
hospital healthcare providers to earlier mobilization and return of oral intake. This 
reduction in length of postoperative hospital stay correlates directly with a significant 
reduction in total hospital charges. The shortening of postoperative hospital stay did not 
come at the expense of increased perioperative complications, mortality, or readmission 
rates, all of which were already at or above national standards. 
As this study illustrates, a critical pathway can be successfully implemented at an 
academic medical center, prompting a significant decrease in length of postoperative 
hospital stay, total hospital charges, and operative times. This can be done in conjunction 
with a significant increase in surgical volume. Components of the critical pathway 
concept from documented goals, to increased awareness, to education of the healthcare 
team all contribute to the efficacy of critical pathways as performance improvement 
tools. When the above mentioned common criticisms of critical pathways are applied, the 
implementation of this pathway is still found to be efficacious. As concerns critical 
pathways taking credit for underlying trends in length of stay, the length of stay for 
pancreaticoduodenectomy had only deceased from a median of 15 days to 13 days at 
Thomas Jefferson University Hospital over the four years prior to the period covered by 
this study.  Clearly, the rate of decrease in length of stay was impacted by 
implementation of this critical pathway. Further, selection bias was limited in this study. 
All patients undergoing pancreaticoduodenectomy at Thomas Jefferson University 
Hospital were treated on the newly introduced clinical pathway and are included in this 
report. 
Of note, the costs of implementing this pathway were minimal. The pathway 
utilized was brought (with minor modifications) to Thomas Jefferson University Hospital 
from another institution at which three of the authors had extensive experience. It was 
successfully implemented without requiring substantial resources. Furthermore, its 
importation argues against the concept that critical pathways must be developed uniquely 
for each institution choosing to utilize them. The ability to transfer effective pathways 
from one institution to another should result in easier implementation, without significant 
expense. 
Critical pathways are an effective tool for quality improvement and cost containment. 
In appropriate settings, they can be implemented quickly and with limited expenditure of 
resources. Making performance improvements requires changing the system at academic 
medical centers. The critical pathway concept with its elements of team building, 
increased awareness of patient care issues, and education of all members of the healthcare 
team is an excellent tool for changing the system. Well suited to the postoperative 
management of complex procedures, critical pathways are one way of meeting the 
challenges of the oncoming “pay for performance” era. 
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Table 1. Critical Pathway for Pancreaticoduodenectomy 
Day of Surgery: 
– Pre-operative heparin 5000 units subcutaneously 
– TED stockings and sequential compression devices 
– Perioperative antibiotics 
– Central access per anesthesia assessment 
– Nasogastric tube placed after induction of anesthesia 
– Two JP drains (one each side) 
– Night of surgery spent in ICU setting 
– Intravenous PCA for analgesia  
– Intravenous PPI 
– Beta-blockade commenced orally preop or intravenously intraop 
Post-operative day #1: 
– Remove nasogastric tube 
– Discontinue antibiotics 
– Start sips of water and ice chips C 30 cc / hr 
– Out of bed ambulating 
– Discontinue sequential compression devices, continue TEDs and heparin 
subcutaneously 
– Continue intravenous beta-blockade and PPI 
– Transfer to floor 
Post-operative day #2: 
– Clear liquid diet 
– Remove Foley catheter 
– Minimize all IV fluids 
– Begin diuresis and continue until discharge or patient reaches pre-
operative weight 
– Continue TEDs, subcutaneous heparin, beta-blockade and PPI until 
hospital discharge 
Post-operative day #3: 
– Regular diet with pancreatic enzymes 
Post-operative day #4: 
– Switch all medications to oral route including analgesics 
– Discontinue all IV fluids 
– Remove JP drain with lowest volume (if appropriate) 
Post-operative day #5: 
– Remove remaining JP drain (if appropriate) 
– Distribute pre-printed discharge instructions 
– Medical oncology and radiation oncology consults (if appropriate) 
Post-operative day #6 or #7: 
– Discharge home 
– Arrange follow up appointment for 4 weeks after discharge 
– Discharge medications: PPI, pancreatic enzymes, analgesics 
 
Table 2. Demographics and Intraoperative Parameters 
 
Pre-pathway Post-pathway p-value 
N 44 91
Surgical volume per month 2.0 7.6  
Demographics    
Age (years)    
Mean ± SE 61.3±2.0 63.9±1.3 NS 
Median 60 66 NS 
Sex    
Female (%) 47 55 NS 
Race    
White (%) 79 87 NS 
AA (%) 12 5 NS 
Other (%) 9 8 NS 
Pathology    
Malignant (%) 74 70 NS 
Operative blood loss (ml) ± SE 549 ± 48 646 ± 29 NS 
Transfused PRBC (units) ± SE 0.72 ± 0.16 0.64 ± 0.13 NS 
Operative time (minutes) ± SE 435 ± 14 379 ± 12 P C 0.0001
Non-operative time in room (minutes) ± SE 95 ± 4 76 ± 2 P C 0.0001
Abbreviations: AA, African American; PRBC, packed red blood cells.
Table 3. Postoperative Parameters 
 
Pre-pathway Post-pathway P-value 
Postoperative complications 
 
Overall rate (%)   
 
44 37 NS 
 Pancreatic fistula (%) 
 
9 2 NS 
 Delayed gastric emptying (%) 
 
7 8 NS 
 Wound infection (%) 
 
9 13 NS 
 Other (%) 
 
25 20 NS 
Peri-operative mortality (%)  
 
2.3 1.1 NS 
Length of Stay (days; median) 
 
13 7 P C 0.0001
Total hospital charges ± SE $240,242 ± $32,490 $126,566 ± $4883 P C 0.0001
Readmission within 30 days (%) 7 7.7 NS 
 
